MYC and acute myeloid leukemia: This reduction in c-myc upregulates TXNIP by inhibiting miR-17-92 and then activates the ASK1-MAPK pathway, which leads to the death of AML cells through the intrinsic apoptotic pathway (Figure 2D) (104).